STOCK TITAN

uniQure NV (NASDAQ: QURE) insider sale of 12,000 shares; 24,333 RSUs vest

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

uniQure NV reports a proposed sale of ordinary shares and recent insider dispositions. The filing notifies a proposed sale of 12,000 ordinary shares through Citigroup Global Markets on 03/04/2026. The notice also lists 24,333 restricted stock units vesting on 03/04/2026 as compensation. Recent reported dispositions by Christian Klemt total 18, + (6,217 and 12,832) ordinary shares sold in February–March 2026 with reported proceeds shown in the excerpt.

Positive

  • None.

Negative

  • None.

Insights

Form 144 lists a proposed brokered sale and RSU vesting on the same date.

The filing shows a proposed sale of 12,000 ordinary shares through Citigroup Global Markets with an execution date of 03/04/2026. It separately records 24,333 RSUs vesting on the same date as compensation.

Timing and sale mechanics are stated plainly; cash‑flow treatment and any holdback or further transfer restrictions are not detailed in the provided excerpt.

Recent dispositions by a named holder are documented alongside the proposed sale.

The excerpt lists two recent dispositions by Klemt Christian: 6,217 shares on 02/25/2026 and 12,832 shares on 03/02/2026, with proceeds shown in the table.

These prior sales are reported as completed; the excerpt does not include price per share or post‑transaction beneficial ownership figures.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does uniQure's Form 144 say about the planned share sale?

The Form 144 notifies a proposed sale of 12,000 ordinary shares through Citigroup Global Markets with an execution date of 03/04/2026. The filing specifies the broker and the planned sale date but does not detail price or final execution status.

Are any restricted stock units (RSUs) mentioned in the filing for QURE?

Yes, the filing lists 24,333 restricted stock units vesting on 03/04/2026 and classifies them as compensation. The excerpt treats vesting as an event separate from the proposed resale transaction.

What insider sales occurred recently for uniQure as shown here?

The excerpt reports two recent dispositions by Klemt Christian: 6,217 shares on 02/25/2026 and 12,832 shares on 03/02/2026, with proceeds shown in the table. These are recorded as sales during the past three months.

Does the filing state how much cash the company will receive from the sale?

The filing does not state that the company will receive proceeds; it lists a brokered sale by an affiliate through Citigroup Global Markets. The excerpt does not specify whether proceeds flow to the issuer or selling holder.

Which broker is handling the proposed resale in the Form 144?

The proposed resale is listed as to be handled by Citigroup Global Markets, with an execution date of 03/04/2026. Broker details appear on the securities line in the excerpt.
Uniqure

NASDAQ:QURE

QURE Rankings

QURE Latest News

QURE Latest SEC Filings

QURE Stock Data

563.12M
58.14M
Biotechnology
Pharmaceutical Preparations
Link
Netherlands
AMSTERDAM